| PERIOD ENDING |
30-Jun-09 |
31-Mar-09 |
31-Dec-08 |
30-Sep-08 |
| Total Revenue |
26,928,000 |
13,074,000 |
13,643,000 |
12,920,000 |
| Cost of Revenue |
-
|
-
|
-
|
-
|
|
| Gross Profit |
26,928,000 |
13,074,000 |
13,643,000 |
12,920,000 |
|
| Operating Expenses |
| Research Development |
-
|
-
|
-
|
-
|
| Selling General and Administrative |
(6,797,000) |
11,253,000 |
(1,038,000) |
2,192,000 |
| Non Recurring |
-
|
-
|
1,349,000 |
-
|
| Others |
27,660,000 |
5,823,000 |
30,191,000 |
20,469,000 |
| |
| Total Operating Expenses |
-
|
-
|
-
|
-
|
|
|
| Operating Income or Loss |
6,065,000 |
(4,002,000) |
(16,859,000) |
(9,741,000) |
|
| Income from Continuing Operations |
| Total Other Income/Expenses Net |
300,000 |
(300,000) |
-
|
672,000 |
| Earnings Before Interest And Taxes |
6,365,000 |
(4,302,000) |
(16,867,000) |
(9,061,000) |
| Interest Expense |
5,782,000 |
6,486,000 |
7,952,000 |
8,263,000 |
| Income Before Tax |
583,000 |
(10,788,000) |
(24,819,000) |
(17,324,000) |
| Income Tax Expense |
(184,000) |
(937,000) |
(967,000) |
7,971,000 |
| Minority Interest |
-
|
-
|
(8,000) |
8,000 |
| |
| Net Income From Continuing Ops |
767,000 |
(9,851,000) |
(23,852,000) |
(25,295,000) |
|
| Non-recurring Events |
| Discontinued Operations |
-
|
-
|
-
|
-
|
| Extraordinary Items |
-
|
-
|
-
|
-
|
| Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
| Other Items |
-
|
-
|
-
|
-
|
|
|
| Net Income |
767,000 |
(9,851,000) |
(23,852,000) |
(25,295,000) |
| Preferred Stock And Other Adjustments |
(1,141,000) |
(378,000) |
(166,000) |
(6,000) |
|
| Net Income Applicable To Common Shares |
($374,000) |
($10,229,000) |
($24,018,000) |
($25,301,000) |
|